Tandem Diabetes - About the company
Tandem Diabetes is a public company based in San Diego (United States), founded in 2008. It operates as a Developer of devices for continuous glucose monitoring and manual insulin delivery. Tandem Diabetes has raised $101M in funding. The company has 10 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Kaleido, Modular Medical and Medtronic Diabetes.
Company Details
Tandem Diabetes is a developer of devices for continuous glucose monitoring and manual insulin delivery. It develops insulin pumps & other products and services that bring innovation, convenience & style to diabetes management. The first product, the t: slim Insulin Pump, features a sleek, modern design, intuitive touch-screen interface, and a rechargeable lithium-polymer battery. The company claims that this makes them closer to producing a fully automated closed-loop automated insulin delivery device that will not require human intervention to release insulin.
- Website
- Social
- Registered Address
- Pr谩膷sk谩 1881 10600 Praha
Key Metrics
Founded Year
2008
Location
San Diego, United States
Stage
Public
Total Funding
in 6 rounds
Latest Funding Round
Ranked
1st among
Annual Revenue
as on Dec 31, 2023
Employee Count
as on Dec 31, 2022
Investment & Acquisitions
Similar Companies
Kaleido &
Exit Details
Public
Legal entities associated with Tandem Diabetes
Tandem Diabetes is associated with 6 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CIN: 45802670 Czech Republic, Active | Jun 29, 1992 | - | - | - |
CIN: 25960369 Czech Republic, Active | Nov 06, 2001 | - | - | - |
CIN: 12043275085 United States, Active | Nov 12, 2013 | - | - | - |
CIN: 1438133 United States, Deadpooled | Jan 06, 2008 | $748M (as on Dec 31, 2023) | - | - |
CIN: 560992306 United States, Active | Dec 31, 1999 | - | 149 (as on Dec 31, 2021) | - |
CIN: 204327508 United States, Active | Dec 31, 1999 | - | 1922 (as on Dec 31, 2022) | - |
Get your free copy of Tandem Diabetes's company profile
Tandem Diabetes's funding and investors
Tandem Diabetes has raised a total funding of $101M over 6 rounds. Its first funding round was on Jan 07, 2010.
Tandem Diabetes has 7 institutional investors including CRG, and .
Here is the list of recent funding rounds of Tandem Diabetes:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
May 15, 2020 | $288M | Post IPO | 2542358 | 6728948 | - |
Jan 16, 2018 | $40M | Post IPO | 9007618 | 5468640 | - |
Jan 12, 2016 | $80M | Conventional Debt | 4668573 | 9182169 |
Access funding benchmarks and valuations. Sign up today!View details of Tandem Diabetes's funding rounds and investors
Tandem Diabetes' founders and board of directors
Tandem Diabetes' employee count trend
Tandem Diabetes has 1,922 employees as of Dec 22. The total employee count is 32.0% more than what it was in Dec 21. Here is Tandem Diabetes's employee count trend over the years:
Uncover Tandem Diabetes' growth story! Sign up today!
Access 秘密研究所 on any website
Our Google Chrome extension lets you view company details while browsing their websites
Tandem Diabetes's Competitors and alternates
Top competitors of Tandem Diabetes include Kaleido, Modular Medical and Medtronic Diabetes. Here is the list of Top 10 competitors of Tandem Diabetes, ranked by 秘密研究所 score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | 秘密研究所 Score |
|---|---|---|---|---|---|
1st | Tandem Diabetes 2008, San Diego (United States), Public | Developer of devices for continuous glucose monitoring and manual insulin delivery | $101M | 77/100 | |
2nd | Kaleido 2013, Utrecht (Netherlands), Series C | Developer of insulin therapy for treating diabetes | $85.3M | Life Sciences Partners, EQT听&补尘辫;听 | 53/100 |
3rd |  Modular Medical 2017, San Diego (United States), Series A | Developer of insulin pump for insulin delivery | $5.28M | - | 50/100 |
4th | Medtronic Diabetes 1993, Northridge (United States), Unfunded | Provides insulin pumps and monitoring solutions | - | - | 43/100 |
5th | Developer of closed loop insulin delivery devices | $22.8M | F-Prime Capital, Eight Roads Ventures听&补尘辫;听 | 34/100 | |
6th | Sooil Development 1981, Seoul (South Korea), Unfunded | Smart insulin infusion pumps | - | - | 26/100 |
7th | U-Pump 2022, Middletown (United States), Unfunded | Provider of insulin delivery solution for diabetes management | - | - | 23/100 |
8th | Rubin Medical 2008, Malmo (Sweden), Funding Raised | Connected insulin pump for managing blood glucose level | - | - | 18/100 |
9th | Apex Diabetes 2006, Wuxi (China), Unfunded | Insulin delivery pump for diabetes and associated supplies | - | - | 18/100 |
10th | Asante Solutions 2006, Sunnyvale (United States), Acqui-Hired | Insulin pump system | - | 17/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Tandem Diabetes's competitors? Click to see the top ones
Tandem Diabetes's Investments and acquisitions
Tandem Diabetes has made 1 investments in companies including CeQur. Tandem Diabetes has also acquired 4 companies including Advanced Microfluidics and Amf Medica. Here is the list of investments & acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Dec 13, 2022 | Acquisition | 2014 | Ecublens, | |
Dec 13, 2022 | Acquisition | 2008 | Grafenau, | |
Jul 21, 2022 | Acquisition | 2014 | Irvine, United States |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Tandem Diabetes
Reports related to Tandem Diabetes
Here is the latest report on Tandem Diabetes's sector:
View
News related to Tandem Diabetes
Media has covered Tandem Diabetes for a total of 45 events in the last 1 year, 30 of them have been about company updates and 1 about partnerships.
鈥�
鈥�
Seeking Alpha鈥�Apr 30, 2025鈥�Tandem Diabetes
鈥�
鈥�
鈥�
鈥�
鈥�
MarketBeat鈥�Apr 06, 2025鈥�Tandem Diabetes
鈥�
Drug Delivery Business鈥�Mar 19, 2025鈥�Tandem Diabetes
鈥�
Business Wire鈥�Mar 19, 2025鈥�Tandem Diabetes
鈥�
Drug Delivery Business鈥�Mar 19, 2025鈥�Tandem Diabetes
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQ's about Tandem Diabetes
Explore our recently published companies
- dAIgnostiX - Bengaluru based, 2018 founded, Unfunded company
- Globe Teleservices - Singapore based, 2012 founded, Unfunded company
- ActionPoint - Bucharest based, 2021 founded, Public company
